Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation

This publication has 9 references indexed in Scilit:

• The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation
  Diabetologia, 2005
• Relapsing diabetes can result from moderately activating mutations in KCNJ11
  Human Molecular Genetics, 2005
• KCNJ11activating mutations in Italian patients with permanent neonatal diabetes
  Human Mutation, 2004
• Glibenclamide Treatment in Permanent Neonatal Diabetes Mellitus due to an Activating Mutation in Kir6.2
  Journal of Clinical Endocrinology & Metabolism, 2004
• Permanent Neonatal Diabetes due to Mutations in KCNJ11 Encoding Kir6.2
  Diabetes, 2004
• Kir6.2 Mutations Are a Common Cause of Permanent Neonatal Diabetes in a Large Cohort of French Patients
  Diabetes, 2004
• Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes
  New England Journal of Medicine, 2004
• Neonatal and very-early-onset diabetes mellitus
  Seminars in Neonatology, 2004
• Glucose-Sensing in Glucagon-Like Peptide-1-Secreting Cells
  Diabetes, 2002